The identification of these targets prompted an exploration of enriched biological processes, revealing pathways related to the negative regulation of interleukin-6-mediated signaling, negative regulation of transforming growth factor beta receptor signaling, and cellular response to virus — processes commonly intertwined with immune response and signaling cascades implicated in cancer progression (41, 42). The gene discussed is IL6; the disease is cancer.